News

One of the reports concerning automation in the biopharmaceutical sector has gone on to show that the market is estimated to grow at a CAGR of 5.7% during the forecast period of 2023–2033. According to the data, the market’s...

Preclinical study making use of stem cells to develop progenitor photoreceptor cells-light detecting cells found in the eye and thereafter transplanting these cells into experimental models of damaged retinas has led to a significant recovery of the vision. The findings...

A new study demonstrates how a medication derived from a natural component used in classical Chinese medicine works over malignant brain tumours in mice, opening up a new path of investigation for glioblastoma treatment. Researchers demonstrated how indirubin, a formulation...

University of Australia scientists, with collaborators from South Korea, China, and, of course, Australia, have gone on to develop a step-wise blueprint so as to create advanced human lung models in the lab, which, according to them, is going...

With COVID-19 cases winding down to manageable numbers (though the virus is still a threat), some experts and parts of the general public can’t help but ask when the next pandemic will be. No one has a concrete answer,...

Cognizant is working with Boehringer Ingelheim, a research-driven biopharmaceutical company, to advance the speed and quality of medicinal therapy development. Leveraging the Veeva Development Cloud, Cognizant will help Boehringer Ingelheim to unify medicinal development processes and data into a...

Science and technology company Merck and XtalPi Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, have jointly published a study that highlights the benefits of combining computational workflows with wet lab experiments to advance...